Alpha Tau Medical Ltd. Form 6-K Summary
Business context and reporting period
Alpha Tau Medical Ltd., an Israeli foreign private issuer, filed this Form 6-K on November 16, 2023, covering November 2023. The filing reports the issuance of a press release titled “Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update.”
Financial and operating metrics
The filing text provided does not include the attached press release or clear values for revenue, net income or loss, cash flow, margins, debt, liquidity, cash balances, or other financial metrics. It states that consolidated balance sheets and statements of operations were included in Exhibit 99.1.
Material changes versus the prior comparable period
The filing text does not provide sufficient information to assess changes versus the prior-year or prior-period comparable results.
Guidance, outlook, risks, and unusual items
The filing identifies a corporate update but does not provide its contents. No guidance, outlook, risk disclosures, contingencies, or unusual items are described in the supplied filing text.
Investor verification points
- Review Exhibit 99.1 for third-quarter 2023 revenue, operating results, cash flow, cash and equivalents, debt, and liquidity.
- Verify management’s corporate update, clinical and regulatory developments, financing plans, and forward-looking statements.
- Compare third-quarter 2023 results with the prior comparable period using the financial statements incorporated by reference.
- Note that the financial statements in Exhibit 99.1 are incorporated by reference into specified Form F-3 and Form S-8 registration statements.